SEC 13F Intelligence

Managers / Q3 2020 · view latest →

COLUMBUS CIRCLE INVESTORS

CIK 0001228773

Reported Value
$2.3B
Q3 2020
Positions
166
Filings on Record
9
2019–present window
Filed
Oct 27, 2020
original filing

Summary

Columbus Circle Investors reported $2.3B in U.S.-listed holdings across 166 positions for Q3 2020.

Its largest position, Horizon Therapeutics Pub L, represents 3.4% of the portfolio.

Compared with Q2 2020, the fund opened 44 new positions and exited 28.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $3.5BQ4 ’18Q1 ’19: $3.9BQ2 ’19: $3.7BQ2 ’19Q3 ’19: $2.7BQ4 ’19: $2.3BQ4 ’19Q1 ’20: $1.8BQ2 ’20: $2.5BQ2 ’20Q3 ’20: $2.3BQ4 ’20: $2.3BQ4 ’20filingsflow.com

Portfolio Composition

By security type
Common Stock: 91.3%Other: 8.2%ADR: 0.5%
  • Common Stock · 91.3% · $2.1B
  • Other · 8.2% · $189M
  • ADR · 0.5% · $11M

Quarter-over-Quarter Changes full breakdown →

Holdings — Q3 2020

Loading…
#IssuerClass% PortfolioValueShares

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q4 2020$2.3B126Jan 20, 202113F-HRchanges · EDGAR ↗
Q3 2020$2.3B166Oct 27, 202013F-HRchanges · EDGAR ↗
Q2 2020$2.5B150Jul 27, 202013F-HRchanges · EDGAR ↗
Q1 2020$1.8B147Apr 28, 202013F-HRchanges · EDGAR ↗
Q4 2019$2.3B152Jan 24, 202013F-HRchanges · EDGAR ↗
Q3 2019$2.7B156Oct 29, 201913F-HRchanges · EDGAR ↗
Q2 2019$3.7B158Aug 2, 201913F-HRchanges · EDGAR ↗
Q1 2019$3.9B146Apr 22, 201913F-HRchanges · EDGAR ↗
Q4 2018$3.5B148Feb 6, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.